This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Csl Behring Ag. Active years: 2017-2019.
Company Filing History:
Years Active: 2017-2019
Title: The Innovative Mind of Marius Loetscher
Introduction
Marius Loetscher, an accomplished inventor based in Gerzensee, Switzerland, has made significant contributions to the field of immunology through his innovative research and patented inventions. With a total of two patents to his name, his work focuses primarily on enhancing the understanding and application of secretory-like immunoglobulins.
Latest Patents
Marius Loetscher's latest patents encompass groundbreaking advancements in the preparation and enrichment of immunoglobulins. His first patent, titled "Compositions comprising secretory-like immunoglobulins," relates to methods for preparing compositions that include secretory-like IgA and/or secretory-like IgM, along with the resulting compositions obtainable by these methods. The second patent, "Process for enriching IgA," introduces a sequential elution process for an anion exchanger aimed at enriching IgA and IgM from IgA-comprising material, facilitating the advantageous separation of monomeric and dimeric IgA.
Career Highlights
Marius Loetscher's work is primarily conducted at CSL Behring AG, a company renowned for its commitment to delivering innovative biotherapies. His patents reflect a deep understanding of immunology and highlight his role in advancing therapeutic options using immunoglobulins to enhance patient care.
Collaborations
Throughout his career, Marius has collaborated with notable colleagues, including Ibrahim El Menyawi and Doreen Siegemund. These partnerships have contributed to the collaborative nature of research and development at CSL Behring, fostering an environment that promotes innovative thinking and effective problem-solving in the biopharmaceutical field.
Conclusion
Marius Loetscher continues to make substantial contributions to immunology through his patents, demonstrating the importance of innovation in advancing healthcare solutions. His work not only enhances our scientific understanding but also paves the way for new therapeutic opportunities, firmly establishing him as a pivotal figure in the realm of immunoglobulin research.